Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Crosslinking and the FDA Approval Process

John Marshall, MD, speaks with Allon Barsam, MB, BS, MA, FRCOphth, regarding crosslinking (CXL) and the FDA approval process. Dr. Marshall shares insight into the research and development of CXL and explains some additional indications for the treatment beyond prevention of keratoconus progression. He also suggests how the FDA should allow for faster adaptation of new technology in the United States.

Corneal Collagen Crosslinking, CXL • FDA Approval/Clearance


1 / 7 Series: Global Innovations